Pew Prescription Project


View All
  • Transparency and the Physician Payments Sunshine Act

    The pharmaceutical industry spent approximately $27 billion in 2012 promoting and marketing its products to physicians. These payments, and those made by the medical device industry, create medical conflicts of interest, which, according to the Institute of Medicine, “threaten the integrity of scientific investigations, the objectivity of professional education, the quality of patient care,... Read More

  • Pew Comments to FDA on Proposed Changes to Sunshine Act Reporting

    On September 2, Pew submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to proposed regulations which would change reporting under the Physician Payment Sunshine Act. Pew supports the elimination of the continuing medical education exclusion, and urges CMS to implement the Sunshine Act in the best interest of consumers. Read More

  • Center for Medicare & Medicaid Services Opens Registration for Open Payments

    The federal government's Centers for Medicare & Medicaid Services yesterday began allowing pharmaceutical and medical device companies to register online for the new “Open Payments” website, authorized under the Physician Payments Sunshine Act to make more transparent the disclosure of financial interactions among physicians. The announcement is a critical first step to bring... Read More